Trial intelligence / Profile preview

Piracetam and rivastigmine in Alzheimer's disease

IRCT201112198430N2Phase 2Completed

Sponsor
Rafsanjan University of Medical Sciences
Start
Mar 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of piracetam and rivastigmine in Alzheimer's disease (AD) (2 arms), sponsored by Rafsanjan University of Medical Sciences. Started Mar 2009; status: completed.

02

Drugs

piracetamrivastigmine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on IRCT201112198430N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201112198430N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call